Streetbeat News

Marketing

BLRX

BioLineRx announced the acceptance of two poster presentations on APHEXDA (motixafortide) for CD34+ Hematopoietic Stem Cell (HSC) mobilization in patients with Multiple Myeloma at the 2024 Tandem Meetings of ASTCT and CIBMTR. This development could indicate positive progress in the clinical research of motixafortide, potentially impacting BioLineRx's market perception and investor interest.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 12:05 pm

KALV

KalVista Pharmaceuticals announced its plans to present Phase 3 data for Sebetralstat at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. This marks a significant milestone in the development of Sebetralstat, potentially impacting the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:33 am

BAC

SBUX

Bank of America Corporation (NYSE:BAC) and Starbucks Corporation (NASDAQ:SBUX) have launched a partnership allowing their cardholders and rewards members to earn additional perks through account linkage. Eligible Bank of America cardholders can earn 2% cash back on qualifying purchases and 1 Star per $2 spent at Starbucks when they link their card to a Starbucks Rewards account. This initiative aims to enhance customer loyalty by offering more valuable benefits.

Portfolio Pulse from Nabaparna Bhattacharya

February 16, 2024 | 11:07 am

SBUX

Starbucks announced the release of accessibility guidelines for its U.S. store portfolio, including a new store in Washington, D.C., featuring optimized acoustics, power-operated doors, and improved features for customers with low vision among other enhancements.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:04 am

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) teased the launch of its new electric-vehicle platform, R2, with a video emphasizing adventure. The global unveiling is set for March 7, with reservations opening during the event for a $100 deposit. The R2 aims to offer a compact design and lower price, targeting the midsize SUV market. Rivian's stock rose 1.41% in premarket trading following the announcement.

Portfolio Pulse from Shanthi Rexaline

February 16, 2024 | 10:18 am

AAPL

Apple Inc.'s iPhone sales in China have continued to decline in 2024 despite offering rare discounts. Analyst Ming-Chi Kuo reported that sales dropped year-on-year through the Chinese Lunar New Year. The decline is attributed to stiff competition from Huawei and a ban on iPhones by Chinese government officials. The Chinese government's advisory on 'security incidents' before the iPhone 15 launch and the expansion of the iPhone ban to more state firms and provinces have exacerbated the situation.

Portfolio Pulse from Rounak Jain

February 16, 2024 | 10:15 am

AAPL

META

Meta Platforms Inc. (META) CEO Mark Zuckerberg and CTO Andrew Bosworth criticized Apple Inc.'s (AAPL) Vision Pro, highlighting its weight and poor weight distribution. Despite acknowledging the Vision Pro's high resolution and low latency, they emphasized Meta's Quest 3 as the superior product in terms of value and overall experience. The Vision Pro, priced at $3,500, has seen returns from users citing discomfort and questioning its value, while the Quest 3 is priced at $499.

Portfolio Pulse from Ananya Gairola

February 16, 2024 | 9:23 am

DE

F

TSLA

Ford CEO Jim Farley encourages investors to focus on Ford's 'Pro' unit over Tesla's Full Self-Driving, highlighting its potential with expected pretax earnings of $8-$9 billion this year. Farley compares Ford Pro to Deere & Co's success and emphasizes its undervaluation. Morgan Stanley's Adam Jonas also sees Ford Pro as a 'cash cow'. Despite challenges, Ford's EV sales in 2023 show significant growth, with Farley optimistic about future profitability.

Portfolio Pulse from Benzinga Neuro

February 16, 2024 | 1:42 am

RNA

Avidity Biosciences will present long-term efficacy and safety data from the MARINA-OLE trial for AOC 1001 in Myotonic Dystrophy Type 1 at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference. John W. Day, a key figure in neuromuscular medicine, will join Avidity's management for the presentation. The event is part of Avidity's investor and analyst series and will be webcast on March 4, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 10:02 pm

FOX

FOXA

FOX News Digital reported an 11% increase in views for January, indicating a significant rise in digital content consumption.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 9:55 pm